Spark Investment Management LLC Corcept Therapeutics Inc Transaction History

Spark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$11.0 - $18.26 $1.28 Million - $2.13 Million	-116,400 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$10.11 - $14.04 $92,001 - $127,763	-9,100 Reduced 7.25%	116,400 $1.38 Million
Q4 2019 Feb 11, 2020	BUY	$12.06 - $16.96 $1.51 Million - $2.13 Million	125,500 New	125,500 $1.52 Million
Q1 2018 May 10, 2018	SELL	$14.59 - $25.5 $606,944 - $1.06 Million	-41,600 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$15.77 - $20.72 $656,032 - $861,952	41,600	41,600 $751,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.99B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.